RELX Stock Price Rises, Institutional Investors Adjust Holdings

Business by 2FIRSTS.ai

Dec.28.2023

RELX Stock Price Rises, Institutional Investors Adjust Holdings

RELX Technology Inc.'s stock price rose 4.8% in midday trading on December 27, with institutional investors adjusting their holdings.

According to financial market analysis on December 27th, RELX Technology Inc. (NYSE: RLX) saw a 4.8% increase in its stock price during midday trading. The company's shares briefly rose to $2.00 and finally closed at $1.98, with approximately 4,474,611 shares changing hands, representing a 47% decrease from the average daily trading volume of 8,412,278 shares.

In recent times, there have been adjustments in the ownership of RELX Technology stocks by institutional investors and hedge funds.

PNC Financial Services Group Inc. acquired stock shares valued at approximately $27,000, while Vanguard Personalized Indexing Management LLC purchased shares worth around $37,000 in the third quarter. In the first quarter, Apollon Wealth Management LLC acquired stock shares valued at approximately $38,000. Clear Street Markets LLC made a new purchase in the fourth quarter, acquiring stock shares valued at around $40,000. Lastly, Mariner LLC purchased stock shares worth approximately $47,000 in the third quarter.

Currently, institutional investors and hedge funds hold 22.68% of RELX Technology company's stocks.

References:

[1] RLX Technology (NYSE:RLX) Stock Price Up 4.8%

Also Read:

[1] Ispire Technology Inc's Stock Price Dropped In Market Trading

[2] RELX Technology's Stock Price Drops in Midday Trading

[3] Ispire Stock Price Drops 4.4% According to Dispatchtribunal

#North America #United States #Market #Technology.#RELX Technology

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Tyumen Regional Parliament in Russia Reviewing Bill to Impose Total Ban on E-Cigarette Sales

Russia's Tyumen Council is considering a bill to ban e-cigarettes and vaping products, sparking concerns about potential risks.

Oct.13 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Russia's Perm Legislators Approve Full Ban on Vape Products in Regional Retail Market

2Firsts, November 28, 2025 — The Legislative Assembly of Perm Krai has passed a law banning the retail sale of vape products and other nicotine-aerosol devices, effective March 1, 2026. Individuals found selling such items will face fines between ₽15,000–₽20,000 (about US $180–240), while companies face ₽50,000–₽100,000 (about US $600–1,200). The ban covers all electronic nicotine delivery systems (ENDS), heated-tobacco devices, and their components, regardless of nicotine content.

Nov.28 by 2FIRSTS.ai

Illegal Market Surges After Kazakhstan Bans E-Cigarettes; Telegram Becomes the Main Trading Channel

Since Kazakhstan banned e-cigarette sales in June 2024, transactions have gone underground, shifting to Telegram and some e-commerce platforms and making enforcement harder; related research indicates the ban has not significantly reduced demand.